Technology News and Research

RSS

DSM Biomedical expands resources and operations in the U.S. and Europe

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

23 Mar 2010

Meridian Bioscience seeks FDA marketing clearance for illumigene C. difficile molecular diagnostic test

Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory.

23 Mar 2010

Cambrex announces acquisition of IEP GmbH

Cambrex Corporation announced it has acquired IEP GmbH, a privately held company that is a leader in the field of industrial biocatalysis. IEP is located in Wiesbaden, Germany and offers cost effective customized biocatalytic process development and sales of enzymes to the pharmaceutical industry, with the ability to utilize its tool box of over 100 proprietary biocatalytic enzymes.

23 Mar 2010

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised -the role of a single protein receptor in breast cells in cancer development and treatment.

22 Mar 2010

Fulcrum Ventures invests $1.25M in Path-Tec

Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC. Founded in 2005, Path-Tec provides clinical, pharmaceutical and research labs with a turnkey solution for kit design, production, client supply management and patient specimen tracking.

22 Mar 2010

Location Based Technologies receives order from Stephen Gould for medical equipment, asset tracking devices

Location Based Technologies, Inc., a leading-edge service provider of personal, pet, and asset location devices, today announced that they have received an order from Stephen Gould Corporation for specialized medical equipment and asset tracking devices that will be utilized by a Southern California medical company.

22 Mar 2010

Ingen Technologies achieves ISO 13485 Certification

Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced today that the company is officially ISO 13485 Certified.

22 Mar 2010

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company’s Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.

22 Mar 2010

Two scientific poster presentations on InVision-Plus connectors featured at SHEA meeting

Two scientific poster presentations that demonstrate the infection prevention capabilities of InVision-Plus® with Neutral Advantage™ technology were featured at the annual conference of the Society for Healthcare Epidemiology of America.

22 Mar 2010

PharmAthene to provide update on contract modification suspension

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in addition to its year end results, it will provide an update on the contract modification suspension it received on Friday, March 19, 2010.

22 Mar 2010

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.

22 Mar 2010

AssistMed launches Duet data transformation platform for capturing handwritten medical information

AssistMed, Inc. today announced the release of a data transformation platform, Duet™, that enables healthcare professionals to dictate or handwrite medical information and receive it back securely as digital input for their healthcare information systems.

22 Mar 2010

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Cancer Research Technology has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the 'protein kinase C' superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.

22 Mar 2010

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

22 Mar 2010

BEMA Granisetron development program: BDSI announces positive meeting with FDA

BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company’s potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI’s plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.

22 Mar 2010

University of Maryland professor honored with the 2010 Stockholm Water Prize

Dr. Rita Colwell, distinguished Professor from the University of Maryland and John Hopkins University's Bloomberg School of Public Health in the United States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's pioneering research on the prevention of waterborne infectious diseases has helped protect the health and lives of millions.

22 Mar 2010

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Today, the U.S. Agency for International Development and The Coca-Cola Company announce an additional joint investment of US$12.7 million in their global partnership, the Water and Development Alliance.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

Speaker Nancy Pelosi spoke on the House floor tonight in support of historic health insurance reform legislation. The House passed the Senate version of health insurance reform legislation by a vote of 219 to 212. That bill now goes to the President for his signature into law. A second bill, to improve the Senate bill, passed by a vote of 220 to 211 and goes to the Senate. Below are the Speaker's remarks.

22 Mar 2010

StockPreacher.com releases investment report on A.P. Pharma

StockPreacher.com announces an investment report featuring A.P. Pharma Inc. (Nasdaq:APPA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Mar 2010

Technology News and Research

DSM Biomedical expands resources and operations in the U.S. and Europe

Meridian Bioscience seeks FDA marketing clearance for illumigene C. difficile molecular diagnostic test

Cambrex announces acquisition of IEP GmbH

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Fulcrum Ventures invests $1.25M in Path-Tec

Location Based Technologies receives order from Stephen Gould for medical equipment, asset tracking devices

Ingen Technologies achieves ISO 13485 Certification

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

Two scientific poster presentations on InVision-Plus connectors featured at SHEA meeting

PharmAthene to provide update on contract modification suspension

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

AssistMed launches Duet data transformation platform for capturing handwritten medical information

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

EmSense releases new EmBand 24 neuromarketing measurement device

BEMA Granisetron development program: BDSI announces positive meeting with FDA

University of Maryland professor honored with the 2010 Stockholm Water Prize

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

StockPreacher.com releases investment report on A.P. Pharma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News